Evertis has selected Honeywell’s Aclar film for its Evercare pharmaceutical brand, aiming to improve packaging solutions within the pharmaceutical sector.
This decision is expected to ensure secure packaging for life-saving medications distributed globally.
Honeywell Energy and Sustainability Solutions sustainability and decarbonisation president Jeff Dormo said: “Honeywell developed Aclar barrier films to help empower our partners in the pharmaceutical industry to develop high-quality packaging materials that meet rigorous standards required in healthcare.
“Aclar has been safely used in the pharmaceutical industry for more than 50 years, and Evertis’ selection of Aclar films supports our shared mission to help promote the safe and effective packaging of life-saving drugs, ultimately improving patient outcomes.”
The Aclar films are claimed to have been designed to protect the efficacy of both prescription and over-the-counter medications.
They are said to provide a superior moisture barrier, which is crucial for maintaining drug stability and extending shelf life.
In addition to enhancing product integrity, Aclar films support the pharmaceutical industry’s shift towards recyclable solutions.
Their unique production methods facilitate easy separation and recycling, contributing to sustainability efforts.
Evertis plans to utilise Aclar in the development of medical-grade polyethylene terephthalate (PET) packaging materials.
PET is recognised for its lightweight and versatile properties, making it a popular choice across various industries.
By integrating Aclar films into its PET packaging, Evertis aims to optimise manufacturing processes and reduce production costs.
Honeywell will collaborate with Evertis to support the design, development, and launch of these new packaging materials.
The PET products incorporating Aclar technology are anticipated to reach the market by 2025.
Evertis Americas CSO Casimiro Sacchetti said: “We are thrilled to partner with Honeywell to advance the next generation of pharmaceutical packaging.
“By combining Evertis’ superior PET film and lamination expertise with Honeywell’s unique Aclar barrier technology, we are now able to offer the pharmaceutical industry premium PET-based films with outstanding thermoforming, sealing, and optical properties – while also meeting sustainability credentials.”
Furthermore, Honeywell said its Advanced Materials business will be rebranded as Solstice Advanced Materials following a tax-free spin-off to shareholders.
This transition is projected to occur by early 2026, with the new company headquartered in Morris Plains, New Jersey.
Solstice Advanced Materials will focus on chemicals and materials, providing advanced technologies in various sectors. These include refrigerants, medical and pharmaceutical packaging, and semiconductor components.
